David A. Gordon

3.1k total citations · 1 hit paper
37 papers, 2.1k citations indexed

About

David A. Gordon is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, David A. Gordon has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Cancer Research. Recurrent topics in David A. Gordon's work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Cancer, Lipids, and Metabolism (6 papers). David A. Gordon is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Cancer, Lipids, and Metabolism (6 papers). David A. Gordon collaborates with scholars based in United States, Germany and Sweden. David A. Gordon's co-authors include Richard E. Gregg, John R. Wetterau, David L. Williams, Haris Jamil, Zemin Yao, Gregory S. Shelness, H Jamil, Elizabeth S. Fenjves, Sven‐Olof Olofsson and Jan Borén and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

David A. Gordon

37 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction

2020 258 citations Jordana B. Cohen, Lei Zhao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Gordon United States	22	781	491	480	418	307	37	2.1k
Michael P. O’Donnell United States	21	795 1.0×	172 0.4×	542 1.1×	275 0.7×	157 0.5×	46	2.5k
William R. Lagor United States	25	1.1k 1.4×	425 0.9×	440 0.9×	386 0.9×	191 0.6×	57	2.0k
Jonathan D. Brown United States	25	2.5k 3.3×	453 0.9×	330 0.7×	311 0.7×	697 2.3×	51	3.8k
Karin G. Stenkula Sweden	24	898 1.1×	234 0.5×	340 0.7×	273 0.7×	562 1.8×	72	1.7k
Peter Cornelius United States	19	1.1k 1.4×	124 0.3×	250 0.5×	201 0.5×	677 2.2×	30	1.9k
Shehla Pervin United States	28	859 1.1×	197 0.4×	118 0.2×	257 0.6×	808 2.6×	42	2.1k
Belén Peral Spain	31	2.2k 2.8×	276 0.6×	250 0.5×	252 0.6×	866 2.8×	53	4.0k
Alfonso Mora Spain	20	1.4k 1.7×	170 0.3×	221 0.5×	184 0.4×	525 1.7×	34	2.5k
Jun Takasaki Japan	25	1.6k 2.0×	123 0.3×	366 0.8×	334 0.8×	515 1.7×	43	2.8k
Anna M. Gómèz‐Foix Spain	26	1.7k 2.1×	110 0.2×	734 1.5×	288 0.7×	751 2.4×	67	2.8k

Countries citing papers authored by David A. Gordon

Since Specialization

Citations

This map shows the geographic impact of David A. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Gordon more than expected).

Fields of papers citing papers by David A. Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Gordon. The network helps show where David A. Gordon may publish in the future.

Co-authorship network of co-authors of David A. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Gordon. A scholar is included among the top collaborators of David A. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Gordon. David A. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reese‐Petersen, Alexander Lynge, et al.. (2023). Endotrophin, a fibroblast matrikine, may be a driver of fibroblast activation in fibro-inflammatory diseases. Frontiers in Molecular Biosciences. 10. 1228232–1228232. 8 indexed citations

Qian, Chenao, Jordana B. Cohen, Qasim Jehangir, et al.. (2022). Abstract 12661: Prognostic Significance of Tubular Injury Biomarkers in Heart Failure With Preserved Ejection Fraction (HFpEF). Circulation. 146(Suppl_1). 1 indexed citations

Hanff, Thomas C., Jordana B. Cohen, Lei Zhao, et al.. (2021). Quantitative Proteomic Analysis of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction. JACC Basic to Translational Science. 6(2). 89–99. 18 indexed citations

Johnson, James A., Soong‐Hoon Kim, Jiang Ji, et al.. (2021). Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate. Journal of Medicinal Chemistry. 64(6). 3086–3099. 14 indexed citations

Ye, Xiang‐Yang, David Yoon, Akbar Nayeem, et al.. (2013). Synthesis and structure–activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Bioorganic & Medicinal Chemistry Letters. 24(2). 654–660. 14 indexed citations

Gordon, David A., et al.. (2011). The Battle for Reform with Al-Qaeda. The Washington Quarterly. 34(3). 103–122. 4 indexed citations

Longo, Kenneth, Elizabeth Govek, Anna Nolan, et al.. (2009). Enhanced Gastrointestinal Motility with Orally Active Ghrelin Receptor Agonists. Journal of Pharmacology and Experimental Therapeutics. 329(3). 1178–1186. 50 indexed citations

Hernández, Andrés S., Mujing Yan, Ramakrishna Seethala, et al.. (2008). Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 18(6). 2067–2072. 3 indexed citations

Coyne, Karin S., Victor Elinoff, David A. Gordon, et al.. (2008). Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine. International Journal of Clinical Practice. 62(6). 925–931. 17 indexed citations

10.

Hernández, Andrés S., Peter T. W. Cheng, R.J. George, et al.. (2007). Discovery, synthesis, and structure–activity studies of tetrazole based growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 17(21). 5928–5933. 22 indexed citations

11.

Jamil, Haris, Ching-Hsuen Chu, John K. Dickson, et al.. (1998). Evidence that microsomal triglyceride transfer protein is limiting in the production of apolipoprotein B-containing lipoproteins in hepatic cells. Journal of Lipid Research. 39(7). 1448–1454. 73 indexed citations

12.

Gordon, David A.. (1997). Recent advances in elucidating the role of the microsomal triglyceride transfer protein in apolipoprotein B lipoprotein assembly. Current Opinion in Lipidology. 8(3). 131–137. 77 indexed citations

13.

Gordon, David A., Haris Jamil, Richard E. Gregg, Sven‐Olof Olofsson, & Jan Borén. (1996). Inhibition of the Microsomal Triglyceride Transfer Protein Blocks the First Step of Apolipoprotein B Lipoprotein Assembly but Not the Addition of Bulk Core Lipids in the Second Step. Journal of Biological Chemistry. 271(51). 33047–33053. 143 indexed citations

14.

Rehberg, E.F., Marie‐Elisabeth Samson‐Bouma, Bernadette Kienzle, et al.. (1996). A Novel Abetalipoproteinemia Genotype. Journal of Biological Chemistry. 271(47). 29945–29952. 67 indexed citations

15.

Gordon, David A., John R. Wetterau, & Richard E. Gregg. (1995). Microsomal triglyceride transfer protein: a protein complex required for the assembly of lipoprotein particles. Trends in Cell Biology. 5(8). 317–321. 111 indexed citations

16.

Gordon, David A.. (1994). Lingcod Fishery and Fishery Monitoring in Southeast Alaska. 7 indexed citations

17.

Fenjves, Elizabeth S., et al.. (1990). Prospects for Epithelial Gene Therapy. PubMed. 53. 215–223. 8 indexed citations

18.

Fenjves, Elizabeth S., David A. Gordon, David R. Williams, & Lorne B. Taichman. (1988). Epidermal Keratinocytes Secrete Apolipoprotein E^a. Annals of the New York Academy of Sciences. 548(1). 160–166. 4 indexed citations

19.

Kirchgessner, Todd G., Camilla Heinzmann, Karen L. Svenson, et al.. (1987). Regulation of chicken apolipoprotein B: cloning, tissue distribution, and estrogen induction of mRNA. Gene. 59(2-3). 241–251. 82 indexed citations

20.

Pruzanski, W., Michelle Russell, David A. Gordon, & M. A. Ogryzlo. (1973). Serum and synovial fluid proteins in rheumatoid arthritis and degenerative joint diseases. The American Journal of the Medical Sciences. 265(6). 483–490. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact